Google Research has released the planetary prediction engine, an AI agent that builds geospatial models from a plain-language question. It was tested on a live Ebola outbreak. Here is what the numbers actually show, and what they do not.
As Congo's Bundibugyo Ebola outbreak hits record size, an AI-assisted model estimates the true toll may be up to triple the confirmed count.
Anthropic published a wet-lab-validated protein binder result on 18 August 2026, then disclosed an 11-month biosecurity classifier gap. The two stories together explain why the world's most capable protein designer is also the one most locked out of virology.
A new preprint tests whether computational and AI forecasting models could have predicted the 2026 Bundibugyo Ebola epidemic in DR Congo before it became one of the largest on record. Here is what the models got right, what they missed, and why it matters for outbreak science.
On 5 August 2026, the FDA approved Moderna's mFLUSIVA, the first mRNA seasonal flu vaccine. The decision is small in label and large in consequence, because the same platform that produced COVID-19 shots in months can now be redirected to a pandemic influenza strain in weeks.
QED Science's AI ranked 57,455 bioRxiv preprints and named a 'top 1%'. Blinded experts sided with the machine over journal prestige in 75% of cases. We examine the evidence, the backlash, and what AI triage means for pandemic-era science.
The first Bundibugyo Ebola vaccine reached human trials just 68 days into the DRC's largest-ever outbreak. What the sprint reveals about AI-era pandemic preparedness.
The Bundibugyo Ebola outbreak is now the largest in DRC history. With no licensed vaccine, three candidates have reached human trials in weeks — a real-world stress test of the 100 Days Mission, AI-assisted drug discovery and outbreak modelling.
Australia just logged its first H5N1 mass-mortality event. Here's how a new wave of AI tools — protein language models, generative antibody pipelines, AI-designed antigens — is being mobilised against the virus, and where the science still falls short.
The Bipartisan Commission on Biodefense added AI as the first new technology priority to the Apollo Program since 2021. The technical evidence behind that decision comes from a red-team exercise in which AI-redesigned toxin sequences slipped past the screening software that DNA synthesis companies rely on.
The 2026 Bundibugyo epidemic is now the largest Ebola outbreak ever recorded in the DRC, against a virus for which no licensed vaccine or therapy exists. It is also the first serious field test of AI-era biology's central promise — and the results are more sobering, and more interesting, than the hype allows.
The US government's July 28 policy prohibits dangerous gain-of-function research outright. But purely computational design of novel biological agents is explicitly not prohibited — it gets an interagency monitoring group instead. Here's what the policy says, why the split matters, and what it doesn't tell us.
A new peer-reviewed study cut AI-redesigned toxin genes into fragments and fed them to four commercial DNA screening tools. Two caught fragments as short as 50 nucleotides. Here's what that means ten weeks before a US screening deadline — and why the authors are still worried.
Genome sequencing published this week places the virus behind Central Africa's fastest-growing Ebola outbreak on a distinct branch of the Bundibugyo family tree — with an evolutionary signal nobody expected. Here is what that means for diagnostics built on the wrong prior, and where AI-assisted sequencing genuinely helps.
OpenAI is giving 100,000 academic researchers free frontier model access with 75+ life science skills. Anthropic's newest flagship refuses to explain mitochondria. Both companies claim to be managing the same biosecurity risk — and the gap between their answers tells you how unsettled AI-for-biology governance really is.
